- Compound N-acetylcysteine
- Class Mucoactive Agents
- Human Studies Yes
- FDA Approved Yes
Mucoactive agents may be used for the management and potential treatment of COVID-related complications. The antiviral, anti-inflammatory, and antioxidant properties of these compounds have also been investigated.
N-acetylcysteine: a mucolytic agent that could potentially be used to treat COVID-19 related complications.
RELATED PROJECTS
